This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.

Remove FDA Remove Generic Medicine Remove Pharmaceutical Companies Related Topics
Packaging Compounding Labelling Vaccines Pharmaceutical Companies More Related Topics >
article thumbnail

STAT+: FTC warns drugmakers they can face legal action over improper patent listings

STAT

SEPTEMBER 14, 2023

The Federal Trade Commission warned pharmaceutical companies they could face legal action if they improperly list patents for brand-name medicines in a Food and Drug Administration registry, the latest effort by the federal government to scrutinize patent moves by drugmakers.

Generic Medicine 126
Generic Medicine Pharmaceutical Companies Pharmaceutical Companies FDA 126
article thumbnail

Why are clinical trials struggling with diversity?

pharmaphorum

MAY 26, 2022

Within pharma and healthcare, where greater representation has been proven to lead to better health outcomes for all patients and the pharmaceutical companies developing medicines, change is also happening. As a Non-Clinical Assessor at MHRA he assessed non-clinical data packages for new and generic medicines.

Packaging 143
Packaging Vaccines Generic Medicine Compounding 143
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 

Stay Connected

Join 18,000+ Insiders by signing up for our newsletter

About
About
Editions
Editions
Topics
Powered by Aggregage | Terms and Conditions | Your California Rights and Privacy Policy
© Aggregage 2024